IL102227A0 - Aminomethyl-substituted 2,3-dihydropyrano(2,3-b)pyridines,their preparation and pharmaceutical compositions containing them - Google Patents

Aminomethyl-substituted 2,3-dihydropyrano(2,3-b)pyridines,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL102227A0
IL102227A0 IL102227A IL10222792A IL102227A0 IL 102227 A0 IL102227 A0 IL 102227A0 IL 102227 A IL102227 A IL 102227A IL 10222792 A IL10222792 A IL 10222792A IL 102227 A0 IL102227 A0 IL 102227A0
Authority
IL
Israel
Prior art keywords
dihydropyrano
pyridines
substituted
aminomethyl
preparation
Prior art date
Application number
IL102227A
Other languages
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL102227A0 publication Critical patent/IL102227A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IL102227A 1991-06-20 1992-06-17 Aminomethyl-substituted 2,3-dihydropyrano(2,3-b)pyridines,their preparation and pharmaceutical compositions containing them IL102227A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4120322A DE4120322A1 (de) 1991-06-20 1991-06-20 Aminomethyl-substituierte 2,3-dihydropyrano(2,3-b)pyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln

Publications (1)

Publication Number Publication Date
IL102227A0 true IL102227A0 (en) 1993-01-14

Family

ID=6434336

Family Applications (1)

Application Number Title Priority Date Filing Date
IL102227A IL102227A0 (en) 1991-06-20 1992-06-17 Aminomethyl-substituted 2,3-dihydropyrano(2,3-b)pyridines,their preparation and pharmaceutical compositions containing them

Country Status (24)

Country Link
US (1) US5250540A (xx)
EP (1) EP0519291B1 (xx)
JP (1) JP3135170B2 (xx)
KR (1) KR930000520A (xx)
CN (1) CN1067656A (xx)
AT (1) ATE147388T1 (xx)
AU (1) AU649331B2 (xx)
CA (1) CA2071398A1 (xx)
CZ (1) CZ177892A3 (xx)
DE (2) DE4120322A1 (xx)
DK (1) DK0519291T3 (xx)
ES (1) ES2095984T3 (xx)
FI (1) FI922874A (xx)
GR (1) GR3022557T3 (xx)
HU (1) HU209890B (xx)
IE (1) IE922004A1 (xx)
IL (1) IL102227A0 (xx)
MX (1) MX9202983A (xx)
NO (1) NO922198L (xx)
NZ (1) NZ243191A (xx)
RU (1) RU2044737C1 (xx)
SK (1) SK177892A3 (xx)
TW (1) TW221439B (xx)
ZA (1) ZA924517B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0714395B1 (en) * 1993-08-19 1999-03-31 Janssen Pharmaceutica N.V. Vasoconstrictive substituted dihydropyranopyridines
EA200000167A1 (ru) * 1997-07-31 2000-10-30 Дюпон Фармасьютикалз Компани Способ получения циклопропилацетилена
US6235957B1 (en) 1998-06-29 2001-05-22 Dupont Pharmaceuticals Company Process for the preparation of cyclopropylacetylene
WO2000000472A1 (en) 1998-06-30 2000-01-06 Du Pont Pharmaceuticals Company 5-ht7 receptor antagonists
WO2000018706A1 (en) 1998-10-01 2000-04-06 Du Pont Pharmaceuticals Company Process for the preparation of cyclopropylacetylene
US6288297B1 (en) 1998-10-01 2001-09-11 Dupont Pharmaceuticals Company Process for the preparation of cyclopropylacetylene
JP2001131177A (ja) * 1999-11-08 2001-05-15 Ohara Yakuhin Kogyo Kk ジベンズ［ｃ，ｆ］イミダゾ［１，５−ａ］アゼピンの製造方法及びその製造中間体

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR930005004B1 (ko) * 1985-04-15 1993-06-11 쟈안센 파아마슈우티카 엔. 부이. 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법
US4748182A (en) * 1986-03-05 1988-05-31 Merrell Dow Pharmaceuticals Inc. Aromatic 2-aminoalkyl-1,2-benzoisothiazol-3(2H)one-1,1-dioxide derivatives and their use as anti-hypertensive and anxiolytic agents
DE3718317A1 (de) * 1986-12-10 1988-06-16 Bayer Ag Substituierte basische 2-aminotetraline
DE3901814A1 (de) * 1988-07-28 1990-02-01 Bayer Ag Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga
CA2015296C (en) * 1989-05-31 2001-08-07 Karnail Atwal Pyranyl cyanoguanidine derivatives
EP0429341A3 (en) * 1989-11-20 1991-11-13 Rhone-Poulenc Sante Heterocyclic derivatives, their preparation and pharmaceuticals containing them
FR2662696A2 (fr) * 1989-12-13 1991-12-06 Rhone Poulenc Sante Antagonistes de la serotonine, leur preparation et medicaments les contenant.

Also Published As

Publication number Publication date
ZA924517B (en) 1993-03-31
JP3135170B2 (ja) 2001-02-13
RU2044737C1 (ru) 1995-09-27
TW221439B (xx) 1994-03-01
HU209890B (en) 1994-11-28
ES2095984T3 (es) 1997-03-01
EP0519291A1 (de) 1992-12-23
AU1739292A (en) 1992-12-24
CA2071398A1 (en) 1992-12-21
FI922874A (fi) 1992-12-21
NZ243191A (en) 1994-04-27
EP0519291B1 (de) 1997-01-08
IE922004A1 (en) 1992-12-30
DE59207824D1 (de) 1997-02-20
MX9202983A (es) 1992-12-01
KR930000520A (ko) 1993-01-15
SK177892A3 (en) 1995-03-08
CZ177892A3 (en) 1993-02-17
CN1067656A (zh) 1993-01-06
DK0519291T3 (da) 1997-06-09
JPH05202054A (ja) 1993-08-10
HUT64959A (en) 1994-03-28
NO922198D0 (no) 1992-06-04
ATE147388T1 (de) 1997-01-15
US5250540A (en) 1993-10-05
AU649331B2 (en) 1994-05-19
GR3022557T3 (en) 1997-05-31
FI922874A0 (fi) 1992-06-18
NO922198L (no) 1992-12-21
HU9202066D0 (en) 1992-09-28
DE4120322A1 (de) 1992-12-24

Similar Documents

Publication Publication Date Title
IL103545A0 (en) 2-aminomethyl-chromans,their preparation and pharmaceutical compositions containing them
IL97912A0 (en) Benzodiazepine derivatives,their preparation and pharmaceutical compositions containing them
IL104006A0 (en) Azaheterocyclylmethyl-chromans,their preparation and pharmaceutical compositions containing them
IL111365A (en) (R)-5-carbamoyl-8-fluoro-3-N,N-disubstituted-amino-3,4-dihydro-2H-1-benzopyrans their preparation and pharmaceutical compositions containing them
HUP9701096A3 (en) Use of benzenesulfonamides for the preparation of pharmaceutical compositions treating disorders of the central nervous system, novel derivatives, process for their preparation and pharmaceutical compositions containing them
IL96167A0 (en) Imidazo(4,5-b)quinolinyloxyalkanoic acid amides,their preparation and pharmaceutical compositions containing them
HUT77667A (hu) Imidazo[4,5-c]kinolin-aminok, ezeket tartalmazó gyógyászati készítmények, és alkalmazásuk
IL64091A (en) Arylimidazo(1,2-a)pyridine acetamide derivatives,their preparation and pharmaceutical compositions containing them
ZA81219B (en) Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
PT86186A (en) Process for the preparation of benzimidazol derivatives and of pharmaceutical compositions containing the same
IL79992A (en) Pyrimidineaminopiperidino-benzimidazoles and-imidazo-(4,5-b)pyridines,process for their preparation and pharmaceutical compositions comprising them
IL102227A0 (en) Aminomethyl-substituted 2,3-dihydropyrano(2,3-b)pyridines,their preparation and pharmaceutical compositions containing them
IL93988A0 (en) Substituted 1,8-naphthyridines,their preparation and medicaments comprising them
IL104005A0 (en) Piperidylmethyl-substituted chroman derivatives,their preparation and pharmaceutical compositions containing them
HU901386D0 (en) Antidotes comprising 2,3-substituted 1,8-naphthyridines, antidoted herbicidal compositions, and process for preparation of the active ingredients
IL95376A0 (en) Pyrido(3,4-b)(1,4)-benzoxazepines,process for their preparation and their use as medicaments
HU901633D0 (en) Process for the preparation of biphenyl derivatives and pharmaceutical compositions containing them
HUT45253A (en) Process for producing imidazo/4,5-b/pyridin-2-one derivatives and pharmaceutical compositions containing them
HU9200400D0 (en) Cinurenic acid derivatives, process for producing them and pharmaceutical compositions containing them
IL89098A (en) Amino- or cyclicamino-acyl substituted pyrido-(2,3-b) (1,4)-and thieno (3,4-b) (1,5) benzodiazepinones, their preparation and pharmaceutical compositions containing them
HUT49054A (en) Process for producing pharmaceutical compositions absorbed through the derm and comprising pyrazolo(1,5-a) pyridine derivatives as active ingredient
PT85001A (en) Process for the preparation of 2,3-dihydro-1-(8-methyl-1,2,4-triazolo ]4,3-b" pyridazin-6-yl)-4 (1h)-pyridinone and of pharmaceutical compositions containing the same
IS3938A (is) Aðferð við framleiðslu nýrra pyrimídó [1',6':1,2]pyridó [3,4-b] indól afleiða og lyfjablandna sem innihalda þær
PT73145B (en) Process for the preparation of 7,8,9,10-tetrahydrofuro<3,2-e>pyrido<4,3-b>indole derivatives having effect on the central nervous system and their application in the preparation of pharmaceutical compositions having effect on the central nervous system
PT84310B (en) Pyrrolo ]3,4-b" pyridine derivatives process for the preparation thereof and pharmaceutical compositions containing them